Korro Bio KRRO
NASDAQ KRRO
$13.06 +0.13 (+1.01%)
As of: Sep 10, 2026 · 3:59 PM EDT

Korro Bio (KRRO) Construction in Progress (2022 - 2024)

Korro Bio's (KRRO) quarterly Construction in Progress came in at $18.3 million in Q2 2024, up 36.57% quarter-over-quarter from $13.4 million in Q1 2024.

Analysis

Korro Bio (KRRO) Construction in Progress (2022 - 2024) Analysis & Trends

Korro Bio (KRRO) has reported Construction in Progress for 3 consecutive years, with $18.3 million the latest figure, recorded in Q2 2024.

  • For the quarter ending Q2 2024, Construction in Progress changed N/A year-over-year to $18.3 million; the trailing twelve-month figure through Jun 2024 stood at $18.3 million (changed N/A YoY), and the FY2023 full-year result was $8.2 million, up 310.0% from the prior year.
  • Construction in Progress grew to $18.3 million in Q2 2024 per KRRO's latest filing, from $13.4 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $18.3 million in Q2 2024 and bottomed at $2.0 million in Q4 2022.
  • Historically, Construction in Progress has averaged $10.5 million across 3 years, with a median of $10.8 million in 2023.
  • The widest YoY moves for Construction in Progress: up 310.0% in 2023, down 310.0% in 2023.
  • Over 3 years, Construction in Progress stood at $2.0 million in 2022, then surged by 310.0% to $8.2 million in 2023, then soared by 123.17% to $18.3 million in 2024.
  • According to Business Quant data, Construction in Progress over the past three periods registered $18.3 million, $13.4 million, and $8.2 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Korro Bio 231.15 Mn 116.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 18.30 Mn
Mar 31, 2024 13.40 Mn
Dec 31, 2023 8.20 Mn
Dec 31, 2022 2.00 Mn